window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI in Pharma

  • Artificial Intelligence,Clinical Development,Data Management,Digital Health,Healthcare leadership,Pharmaceuticals and therapeutics,Research & Development

    AI and medical affairs strategy set to redefine life sciences in 2026

    Artificial intelligence, shifting healthcare professional behaviour and rising pressure on [...]

    February 18, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Digital Health,Pharmaceuticals and therapeutics,Technology and platforms

    From outputs to outcomes: Saama’s Derek Lawrence on why clinical data management must change

    Clinical data management is under pressure to evolve as trials [...]

    January 20, 2026
  • Artificial Intelligence,Biotech,Drug Development,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    CytoReason unveils LINA, AI agent accelerated by NVIDIA for pharma R&D

    CytoReason has unveiled LINA, an AI agent designed to support [...]

    January 13, 2026
  • Artificial Intelligence,Data Management,Digital Health,Healthcare leadership,Market Access & Commercialization,Pharmaceuticals and therapeutics,Technology and platforms

    Veeva announces expanded partnership with Roche to deliver next-generation AI CRM

    Veeva Systems has extended its partnership with Roche Pharmaceuticals by [...]

    November 24, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Clinical studies,Market Access & Commercialization

    KBI Biopharma CBO Katie Edgar on ADCs, biologics, and digital innovation in drug development

    Discover Pharma caught up with Katie Edgar, chief business officer [...]

    November 13, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Data Management,Peptides,Research & Development

    Solvias CSO Danny Galbraith on peptides, ADCs and AI driving drug development innovation

    Discover Pharma caught up with Danny Galbraith, chief scientific officer [...]

    November 7, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Clinical Development,Data Management,Partnerships & Funding

    IQVIA and Veeva agree global clinical and commercial collaboration

    IQVIA and Veeva Systems have announced the resolution of all [...]

    August 30, 2025
  • Artificial Intelligence,Clinical Trials,Data Management,Regulatory Affairs

    Advarra launches AI engine to enhance operational efficiency in clinical trials

    Advarra has introduced Braid, an artificial intelligence (AI) engine designed [...]

    August 12, 2025
  • Market Access & Commercialization,Patient Centricity,Technology and platforms

    Pharma’s digital reckoning: Why SEO is now a strategic imperative

    With growing debate over a potential ban on DTC TV [...]

    July 29, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Partnerships & Funding,Research & Development,Technology and platforms

    AI-powered bioreactor project aims to transform biologics manufacturing

    A Canada–UK collaboration is developing an AI-driven bioreactor platform designed [...]

    July 25, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top